A novel Cx32 mutation causes X-linked Charcot-Marie-Tooth disease with brainstem involvement and brain magnetic resonance spectroscopy abnormalities
- 作者M. R. Murru; A. Vannelli; G. Marrosu; E. Cocco; D. Corongiu; S. Tranquilli; M. V. Cherchi; M. Mura; L. Barberini; G. Mallarini; M. G. Marrosu
- 卷第27卷
- 期第1期
- 印刷ISSN1590-1874
- 电子ISSN1590-3478
- 文件大小101.95KB
- 发表时间2006-04
- DOI10.1007/s10072-006-0560-8
- 页码18-23
The way forward to treatment optimisation in multiple sclerosis2004
Translating new insights into treatment optimisation in multiple sclerosisFranz Fazekas; Bernd C. Kieseier · 2009
Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?N. Grigoriadis; G. Deretzi; N. Artemis; N. Tascos; I. Milonas · 2006
Differential diagnosis of acute myelopathiesA. Ghezzi; S. M. Baldini; M. Zaffaroni · 2001
The prognosis of idiopathic optic neuritisA. Ghezzi; V. Martinelli; M. Rodegher; M. Zaffaroni; G. Comi · 2000
Erectile impotence in multiple sclerosis: a neurophysiological studyA. Ghezzi; G. M. Malvestiti; S. Baldini; M. Zaffaroni; A. Zibetti · 1995
Neuroimmunological correlates of cognitive impairmentM. Zaffaroni · 1998
Polyneuritic onset in multiple sclerosisD. Caputo; A. Ghezzi; M. Zaffaroni; A. Zibetti · 1982
Intensive immunosuppression in multiple sclerosisM. Zaffaroni; A. Ghezzi; G. Comi · 2006
30 INVITED Peritoneal MesotheliomaM. Deraco; D. Baratti; S. Kusamura; N. Zaffaroni; F. Parrone; S. Pilotti; A. Cabras · 2011